NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/09/2026
Back to search
Official data from USPTO
ONCOJET PLASMA SOLUTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
07/09/2026
Trademark type
Combined
Nice classes
5, 10, 44
Filing date
10/21/2016
Registration date
10/30/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2025
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
DE
Examiner
LEIPZIG, MARC J
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the dark red wording "ONCOJET" above the grey wording "PLASMA SOLUTION".
Holders and representatives
Holders
Leibniz-Institut für Plasmaforschung und Technologie e.V.
Representatives
Nicholas D Wells Legends Law Group, PLLC
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary and therapeutic preparations and substancespharmaceutical preparations for the treatment of cancer and cancer-related conditionsveterinary preparations for the treatment of cancer and cancer-related conditions in mammals; sanitary preparations for medical purpose; plasters for medical purposes; medical dressings; teeth filing material and dental impression materials; disinfectants; all aforementioned products particularly for use in oncology
Class 10
Instruments and devices for plasma medicalveterinary and therapeutic purposesatmospheric pressure plasma jets and dielectric barrier discharges in the nature of electric therapy apparatus for direct treatment in the nature of treating tumors and tumor cellsmedical plasma devices in the nature of ultrasonic therapy apparatus and liquid dispensers for medical use for generating and applying one or more liquid-based active agents for use in medical tumor therapy; pumps for medicalveterinary and therapeutics usedispenser pumps for medical purposes for mixing gaseous or liquid agents and for generating low pressure regimes for easier plasma ignition; devices and apparatus for administering or applying medicines and substances for medicalveterinary and therapeutic useneedle-based and needle-free injection systems consisting primarily of needle-free syringes and jet injectors for applying one or more liquid-based active agentsplasma generated reactive gases or direct atmospheric pressure plasma; devices and apparatus for plasma medical useplasma sources being plasma jets or dielectric barrier discharges for use in the treatment of cancer; and replacement parts and fittings for the aforementioned products; all aforementioned products particularly for use in oncology
Class 44
Medical services; veterinary services; and medical therapeutic services in the field of oncology; healthcare and beauty care for humans and animals; all aforementioned services particularly tailored for the field of oncology
Publications
History of USPTO decisions and trademark events.
46 publications found
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/16/2026
C71T
CANCELLED SECTION 71
05/16/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/30/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/12/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/06/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
02/05/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/30/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/28/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/12/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/12/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/14/2018
PUBO
PUBLISHED FOR OPPOSITION
08/14/2018
GPNX
NOTIFICATION PROCESSED BY IB
08/10/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/25/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/25/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/25/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/29/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/28/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/28/2018
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
06/05/2018
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
06/05/2018
CNCF
ACTION CONTINUING A FINAL - COMPLETED
06/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/09/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/11/2017
GNFR
FINAL REFUSAL E-MAILED
11/11/2017
CNFR
FINAL REFUSAL WRITTEN
11/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/19/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/18/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/18/2017
ATRV
ATTORNEY REVIEW COMPLETED
08/25/2017
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
08/25/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/17/2017
RFNT
REFUSAL PROCESSED BY IB
05/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/20/2017
RFRR
REFUSAL PROCESSED BY MPU
04/20/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/18/2017
CNRT
NON-FINAL ACTION WRITTEN
04/17/2017
MAFR
APPLICATION FILING RECEIPT MAILED
04/15/2017
DOCK
ASSIGNED TO EXAMINER
04/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/06/2017
Continuous trademark protection
Get notified about every new filing that threatens ONCOJET PLASMA SOLUTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.